129 related articles for article (PubMed ID: 3510209)
1. Receptor aggregation is necessary for activation of the soluble insulin receptor kinase.
Heffetz D; Zick Y
J Biol Chem; 1986 Jan; 261(2):889-94. PubMed ID: 3510209
[TBL] [Abstract][Full Text] [Related]
2. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.
Fan Z; Lu Y; Wu X; Mendelsohn J
J Biol Chem; 1994 Nov; 269(44):27595-602. PubMed ID: 7961676
[TBL] [Abstract][Full Text] [Related]
3. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
4. Receptor cross-linking restores an insulin metabolic effect altered by mutation on tyrosine 1162 and tyrosine 1163.
Debant A; Ponzio G; Clauser E; Contreres JO; Rossi B
Biochemistry; 1989 Jan; 28(1):14-7. PubMed ID: 2650737
[TBL] [Abstract][Full Text] [Related]
5. Direct demonstration that receptor crosslinking or aggregation is important in insulin action.
Kahn CR; Baird KL; Jarrett DB; Flier JS
Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4209-13. PubMed ID: 279910
[TBL] [Abstract][Full Text] [Related]
6. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.
Fjeld JG; Michaelsen TE; Nustad K
Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231
[TBL] [Abstract][Full Text] [Related]
7. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
[TBL] [Abstract][Full Text] [Related]
9. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
11. A general and mild procedure for the purification of rabbit Fab' antibodies.
Ishikawa E; Yoshitake S
J Immunol Methods; 1980; 38(1-2):117-23. PubMed ID: 7452000
[TBL] [Abstract][Full Text] [Related]
12. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
[TBL] [Abstract][Full Text] [Related]
13. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.
Siegall CB; Gawlak SL; Chin JJ; Zoeckler ME; Kadow KF; Brown JP; Braslawsky GR
Bioconjug Chem; 1992; 3(4):302-7. PubMed ID: 1390985
[TBL] [Abstract][Full Text] [Related]
15. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
[TBL] [Abstract][Full Text] [Related]
16. Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab')2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG.
Williams JM; Ben-Smith A; Hewins P; Dove SK; Hughes P; McEwan R; Wakelam MJ; Savage CO
J Am Soc Nephrol; 2003 Mar; 14(3):661-9. PubMed ID: 12595502
[TBL] [Abstract][Full Text] [Related]
17. The role of antireceptor antibodies in stimulating phosphorylation of the insulin receptor.
Zick Y; Rees-Jones RW; Taylor SI; Gorden P; Roth J
J Biol Chem; 1984 Apr; 259(7):4396-400. PubMed ID: 6538568
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic properties of Fab and F(ab')2 fragments of rabbit anti-human beta2-microglobulin for human lymphocytes.
Ringdén O; Johansson BG
Scand J Immunol; 1977; 6(4):281-9. PubMed ID: 67634
[TBL] [Abstract][Full Text] [Related]
19. Purification of recombinant chimeric B72.3 Fab' and F(ab')2 using streptococcal protein G.
Proudfoot KA; Torrance C; Lawson AD; King DJ
Protein Expr Purif; 1992 Oct; 3(5):368-73. PubMed ID: 1458050
[TBL] [Abstract][Full Text] [Related]
20. Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to rat renal tubular epithelial antigen.
Salant DJ; Madaio MP; Adler S; Stilmant MM; Couser WG
Kidney Int; 1982 Jan; 21(1):36-43. PubMed ID: 7043051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
